Follow Elekta


Elekta | Focus Magazine

What do the best U.S. cancer hospitals have in common?


Ten out of ten of the top cancer hospitals in the United States all use one or more treatment solution from Elekta

U.S. News & World Report recently evaluated 899 hospitals to determine which ones offered the very best cancer care. The common denominator for the highest-ranking hospitals is that they all rely on Elekta’s cutting-edge cancer treatment equipment.

The solutions range from our flagship Elekta Unity MR-Linac, that enables a scan-plan-treat approach for accurate dose delivery with real-time visualization of the tumor, to brachytherapy devices designed for precise, targeted treatment of various cancers such as cervical, prostate, breast, skin and rectal. Eight of the top ten hospitals can offer patients with brain tumors or other brain diseases Leksell Gamma Knife® treatment for sub-millimeter precision with lower dose to healthy tissue compared to other SRS modalities.1

Many of these renowned cancer clinics include Elekta linear accelerators, such as Versa HD, Elekta Infinity or Elekta Synergy®, in their arsenal to beat cancer and improve the outcomes and lives of their patients.

In addition, several of the top cancer hospitals in the U.S. also use Elekta’s award-winning MOSAIQ® Oncology Information System, which helps clinicians capture the entire oncology chart in a single integrated solution, and Monaco® treatment planning system, that integrates planning capabilities for a streamlined user experience.

U.S. News states that its methodologies are based largely on objective measures such as risk-adjusted survival and discharge-to-home rates, volume, and quality of nursing, among other care-related indicators.

1Ma L, Nichol A, Hossain S, et al. (2014) “Variable dose interplay effects across radiosurgical apparatus in treating multiple brain metastases”. Int J CARS. Published online: 20 April 2014. doi:10.1007/s11548-014-1001-4

Did you like the article? Please share on your channels.

Share Share Share